Direct Regulation of CLOCK Expression by REV-ERB

por Crumbley, Christine, Burris, Thomas P.
Publicado 2011

Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases

por Griffett, Kristine, Burris, Thomas P.
Publicado 2023

Inhibition of RORα/γ suppresses atherosclerosis via inhibition of both cholesterol absorption and inflammation

por Billon, Cyrielle, Sitaula, Sadichha, Burris, Thomas P.
Publicado 2016

Metabolic Characterization of a Novel RORα Knockout Mouse Model without Ataxia

por Billon, Cyrielle, Sitaula, Sadichha, Burris, Thomas P.
Publicado 2017

Regulation of Expression of Citrate Synthase by the Retinoic Acid Receptor-Related Orphan Receptor α (RORα)

por Crumbley, Christine, Wang, Yongjun, Banerjee, Subhashis, Burris, Thomas P.
Publicado 2012

LXR-Mediated Inhibition of CD4(+) T Helper Cells

por Solt, Laura A., Kamenecka, Theodore M., Burris, Thomas P.
Publicado 2012

Therapeutic Effect of a Synthetic RORα/γ Agonist in an Animal Model of Autism

por Wang, Yongjun, Billon, Cyrielle, Walker, John K., Burris, Thomas P.
Publicado 2015

REV-ERB agonism improves liver pathology in a mouse model of NASH

por Griffett, Kristine, Bedia-Diaz, Gonzalo, Elgendy, Bahaa, Burris, Thomas P.
Publicado 2020

Regulation of p53 Stability and Apoptosis by a ROR Agonist

por Wang, Yongjun, Solt, Laura A., Kojetin, Douglas J., Burris, Thomas P.
Publicado 2012

Rev-erbα heterozygosity produces a dose-dependent phenotypic advantage in mice

por Welch, Ryan D., Billon, Cyrielle, Kameric, Amina, Burris, Thomas P., Flaveny, Colin A.
Publicado 2020

Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle

por Welch, Ryan D., Billon, Cyrielle, Valfort, Aurore-Cecile, Burris, Thomas P., Flaveny, Colin A.
Publicado 2017

Distinct roles for REV-ERBα and REV-ERBβ in oxidative capacity and mitochondrial biogenesis in skeletal muscle

por Amador, Ariadna, Campbell, Sean, Kazantzis, Melissa, Lan, Gary, Burris, Thomas P., Solt, Laura A.
Publicado 2018

REV-ERB activation as a novel pharmacological approach for treating inflammatory pain

por Makhija, Sangeet, Griffett, Joshua D., Veerakanellore, Giri Babu, Burris, Thomas P., Elgendy, Bahaa, Griffett, Kristine
Publicado 2023

Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression

por Amador, Ariadna, Wang, Yongjun, Banerjee, Subhashis, Kameneka, Theodore M., Solt, Laura A., Burris, Thomas P.
Publicado 2016

Correction: Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression

por Amador, Ariadna, Wang, Yongjun, Banerjee, Subhashis, Kamenecka, Theodore M., Solt, Laura A., Burris, Thomas P.
Publicado 2016

Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation

por Amador, Ariadna, Huitron-Resendiz, Salvador, Roberts, Amanda J., Kamenecka, Theodore M., Solt, Laura A., Burris, Thomas P.
Publicado 2016

The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis

por Griffett, Kristine, Welch, Ryan D., Flaveny, Colin A., Kolar, Grant R., Neuschwander-Tetri, Brent A., Burris, Thomas P.
Publicado 2015

A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis

por Sengupta, Monideepa, Abuirqeba, Suomia, Kameric, Amina, Cecile-Valfort, Aurore, Chatterjee, Arindam, Griffett, Kristine, Burris, Thomas P., Flaveny, Colin A.
Publicado 2021

Artemisia scoparia Enhances Adipocyte Development and Endocrine Function In Vitro and Enhances Insulin Action In Vivo

por Richard, Allison J., Fuller, Scott, Fedorcenco, Veaceslav, Beyl, Robbie, Burris, Thomas P., Mynatt, Randall, Ribnicky, David M., Stephens, Jacqueline M.
Publicado 2014

SR9009 administered for one day after myocardial ischemia-reperfusion prevents heart failure in mice by targeting the cardiac inflammasome

por Reitz, Cristine J., Alibhai, Faisal J., Khatua, Tarak N., Rasouli, Mina, Bridle, Byram W., Burris, Thomas P., Martino, Tami A.
Publicado 2019